Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,238 trials

NCT07711002
Recruiting
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Phase 3 · Austria, Brazil, Canada, Switzerland, China, Germany, Spain, France, United Kingdom, Hong Kong, Hungary, India, Italy, Japan, South Korea, Poland, Puerto Rico, Thailand, Taiwan, United States · 182 sites
Registry update: 15 Oct 2026
NCT07650448
Recruiting
WATER IV PCa (AS Sub-study)
Not applicable · Hong Kong, United States · 28 sites
Registry update: 6 Nov 2026
NCT07813637
Recruiting
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
Phase 1 · United States · 1 site
Registry update: 17 Sept 2026
NCT07543055
Recruiting
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Phase 1 · United States · 3 sites
Registry update: 24 Sept 2026
NCT07226713
Recruiting
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
Phase 2 · United States · 1 site
Registry update: 9 Sept 2026
NCT07730021
Recruiting
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Phase 1/2 · Japan, United States · 4 sites
Registry update: 26 Oct 2026
NCT07644598
Recruiting
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
Phase 2 · United States · 1 site
Registry update: 20 Aug 2026
NCT07237269
Recruiting
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Phase 2 · United States · 1 site
Registry update: 19 Oct 2026
NCT07802704
Recruiting
A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
Phase 3 · Australia, Canada, Japan, South Korea · 6 sites
Registry update: 2 Oct 2026
NCT07847385
Recruiting
Tractography-Guided Nerve-Sparing in Prostate Cancer
Not applicable · Switzerland · 1 site
Registry update: 29 Sept 2026
NCT07560748
Recruiting
Prospective Prostate Cancer Infrastructure
Not applicable · Netherlands · 1 site
Registry update: 10 Sept 2026
NCT07576335
Recruiting
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Phase 2 · Australia · 3 sites
Registry update: 23 Oct 2026
NCT07569926
Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Phase 4 · United States · 6 sites
Registry update: 5 Nov 2026
NCT07649122
Recruiting
This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
Phase 3 · China · 2 sites
Registry update: 15 Sept 2026
NCT07542379
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
Early phase 1 · China · 1 site
Registry update: 4 Sept 2026
NCT07751133
Recruiting
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Phase 3 · United Kingdom · 4 sites
Registry update: 4 Nov 2026
NCT07735377
Recruiting
A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
Phase 1 · China · 1 site
Registry update: 8 Sept 2026
NCT07578519
Recruiting
Radiation Treatment of the Prostate That is Specially Adjusted for Each Person
Phase 2 · Canada · 1 site
Registry update: 3 Sept 2026
NCT07224009
Recruiting
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
Phase 2 · United States · 1 site
Registry update: 8 Sept 2026
NCT07841184
Recruiting
Modified Saddle Block vs Spinal Anesthesia for TURP
Phase 4 · Pakistan · 1 site
Registry update: 25 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.